miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor. (Q53508723)

15 May 2018

title

miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor. (English)

1 reference

15 May 2018

author name string

Xianjuan Shen

1

1 reference

15 May 2018

Yuehua Guo

2

1 reference

15 May 2018

Jiajia Yu

3

1 reference

15 May 2018

Jing Qi

4

1 reference

15 May 2018

Wei Shi

5

1 reference

15 May 2018

Xinhua Wu

6

1 reference

15 May 2018

Hongbing Ni

7

1 reference

15 May 2018

Shaoqing Ju

8

1 reference

15 May 2018

publication date

14 May 2015

1 reference

15 May 2018

Clinical and Experimental Medicine

published in

1 reference

15 May 2018

volume

16

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

307-316

1 reference

15 May 2018

Quality of life and supportive care in multiple myeloma

cites work

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Multiple myeloma: the bone marrow microenvironment and its relation to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Effects of proteasome inhibitors on bone cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Bone marrow microenvironment and the identification of new targets for myeloma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

microRNAs in cancer management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

NF-kappaB in the pathogenesis and treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10238-015-0355-4

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

21 January 2018

1 reference

12 December 2020

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma

1 reference

12 December 2020

MicroRNA signatures characterize multiple myeloma patients

1 reference

12 December 2020

B cell-activating factor: its clinical significance in multiple myeloma patients

1 reference

12 December 2020

10.1007/S10238-015-0355-4

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018